We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Brown-Forman Class B
BF.B
$12B
| $7.69M | 0.05% |
+253,236
| New | +$7.86M |
|
327
Liberty Broadband Class C
LBRDK
$4.15B
| $7.6M | 0.05% |
106,350
+28,505
| +37% | +$1.9M |
|
|
XTLY
328
DELISTED
Xactly Corporation
XTLY
| $7.58M | 0.05% |
514,610
+496,834
| +2,795% | +$6.66M |
|
329
FTI Consulting
FCN
$4.82B
| $7.47M | 0.05% |
167,727
-14,389
| -8% | -$622K |
|
330
Liberty Media Series A
FWONA
$22.3B
| $7.47M | 0.05% |
+272,300
| New | +$5.97M |
|
|
NVO
331
Novo Nordisk
NVO
$216B
| $7.42M | 0.05% |
+356,608
| New | +$8.84M |
|
|
DERM
332
DELISTED
Dermira, Inc.
DERM
| $7.32M | 0.05% |
216,317
+174,625
| +419% | +$5.62M |
|
|
WFT
333
DELISTED
Weatherford International plc
WFT
| $7.29M | 0.05% |
1,296,766
-2,789,078
| -68% | -$15.8M |
|
|
FLIR
334
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $7.27M | 0.05% |
+231,378
| New | +$7.29M |
|
335
Mastercard
MA
$477B
| $7.15M | 0.05% |
70,274
-1,863
| -3% | -$179K |
|
336
MACOM Technology Solutions
MTSI
$20.4B
| $7.15M | 0.05% |
168,852
-281,282
| -62% | -$11M |
|
337
Home Depot
HD
$332B
| $7.04M | 0.05% |
54,713
-181,452
| -77% | -$24.2M |
|
|
TGNA
338
DELISTED
TEGNA Inc
TGNA
| $6.99M | 0.05% |
499,595
-33,707
| -6% | -$474K |
|
339
Ametek
AME
$55.5B
| $6.99M | 0.05% |
146,188
-208,899
| -59% | -$9.95M |
|
|
DISH
340
DELISTED
DISH Network Corp.
DISH
| $6.93M | 0.05% |
126,573
+118,384
| +1,446% | +$6.13M |
|
|
DYN
341
DELISTED
Dynegy, Inc.
DYN
| $6.91M | 0.05% |
+557,539
| New | +$7.91M |
|
|
CLCD
342
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $6.85M | 0.05% |
+179,480
| New | +$2.65M |
|
|
JOY
343
DELISTED
Joy Global Inc
JOY
| $6.84M | 0.05% |
+246,769
| New | +$6.54M |
|
|
SCAI
344
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $6.77M | 0.05% |
+138,831
| New | +$6.39M |
|
345
Independence Realty Trust
IRT
$3.92B
| $6.75M | 0.05% |
+750,000
| New | +$6.99M |
|
|
KLXI
346
DELISTED
KLX Inc.
KLXI
| $6.74M | 0.05% |
227,204
+101,618
| +81% | +$2.92M |
|
347
Enterprise Products Partners
EPD
$83.8B
| $6.68M | 0.05% |
+241,774
| New | +$6.68M |
|
|
NVRO
348
DELISTED
NEVRO CORP.
NVRO
| $6.59M | 0.05% |
+63,140
| New | +$5.7M |
|
349
Nomad Foods
NOMD
$1.64B
| $6.59M | 0.05% |
+557,231
| New | +$5.6M |
|
350
BWX Technologies
BWXT
$16B
| $6.56M | 0.05% |
170,856
+114,991
| +206% | +$4.34M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.